| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/01/2007 | US20070048306 Method for generating anti-variable region monoclonal antibodies |
| 03/01/2007 | US20070048305 CD147 binding molecules as therapeutics |
| 03/01/2007 | US20070048304 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain |
| 03/01/2007 | US20070048302 Interleukin-2 (IL-2); treating metastatic cancer, autoimmune disorders, and viral infections such as HIV by administering a peptide that peptide binds to the IL-2 beta chain |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 03/01/2007 | US20070048300 Antibodies having altered effector function and methods for making the same |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048282 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 03/01/2007 | US20070048277 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070048276 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070048275 Hepatitis C; antiviral polypeptide |
| 03/01/2007 | US20070048274 Homogeneous preparations of IL-28 and IL-29 |
| 03/01/2007 | US20070048260 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048259 Cytokine zalpha11 ligand |
| 03/01/2007 | US20070048256 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 03/01/2007 | US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | CA2620934A1 Compositions and methods for determining protein interactions using tat signal sequence and marker protein |
| 03/01/2007 | CA2619943A1 Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria |
| 03/01/2007 | CA2619825A1 Proteolysis resistant antibody preparations |
| 03/01/2007 | CA2615761A1 Humanized anti-ca6 antibodies and methods of using the same |
| 02/28/2007 | EP1757941A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 02/28/2007 | EP1757937A2 Antagonists of HMG1 for treating inflammatory conditions |
| 02/28/2007 | EP1757700A2 Cell culture process for glycoproteins |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757688A1 Method of disulfide crosslink forming type in vitro protein synthesis |
| 02/28/2007 | EP1757683A1 Method of making a mutated type IIT endonuclease which has nicking activity |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757616A2 Semaphorin receptors |
| 02/28/2007 | EP1757614A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 02/28/2007 | EP1756293A2 High throughput cancer pharmaceutical screening using drosophila |
| 02/28/2007 | EP1756276A2 Crustacean expression vector |
| 02/28/2007 | EP1756275A1 Method for obtaining mature protease by enzymatic digestion |
| 02/28/2007 | EP1756264A1 Fermentation process using faba beans as notrogen source |
| 02/28/2007 | EP1756159A1 C1q family member proteins with altered immunogenicity |
| 02/28/2007 | EP1756144A2 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof |
| 02/28/2007 | EP1633381A4 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 02/28/2007 | EP1466972B1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof |
| 02/28/2007 | EP1436002B1 Use of peptide vectors to improve the immune response to antigens |
| 02/28/2007 | EP1375639B1 Selection media for beauveriolide i or beauveriolide iii and process for selectively producing these substances |
| 02/28/2007 | EP1346041B1 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 02/28/2007 | EP1326995B8 Method for synthesising peptides, peptide mimetics and proteins |
| 02/28/2007 | EP1077999B1 Moraxella catharralis proteins |
| 02/28/2007 | EP0945506B1 Proteine avec une activite de suppression du vieillissement |
| 02/28/2007 | EP0888122B1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 02/28/2007 | EP0833840B1 Hypoxia inducible factor-1 and method of use |
| 02/28/2007 | EP0770628B9 Reconstituted human antibody against human interleukin-8 |
| 02/28/2007 | EP0758390B1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/28/2007 | CN1922316A Mutants of anti-cd40 antibody |
| 02/28/2007 | CN1922313A Acid alpha-glucosidase and fragments thereof |
| 02/28/2007 | CN1922210A Monovalent antibody fragments useful as therapeutics |
| 02/28/2007 | CN1922199A Ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/28/2007 | CN1920049A Small molecule bioactive peptide, preparation method, composition and application thereof |
| 02/28/2007 | CN1920040A Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 02/28/2007 | CN1920027A Human hPTP gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920026A Human hMnk2 gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920025A Human hNP25 gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920024A Human hARPP-21 gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920023A Human heIF2a gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920022A Human hMKPx gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920020A Gene engineering producing method of antibacterial peptide Pexiganan |
| 02/28/2007 | CN1920019A Gene engineering producing method of antibacterial peptide IB-367 |
| 02/28/2007 | CN1920011A Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/28/2007 | CN1302010C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 02/27/2007 | US7183403 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183401 Tumor suppressor protein (designated NOEY2) expressed in normal ovarian and breast surface epithelial cells but absent or down-regulated in ovarian and breast cancer cells; vectors, host cells, detection kits |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183399 Nucleotide sequences coding reef coral fluorescent proteins for use as diagnostic tool in genetic engineering |
| 02/27/2007 | US7183393 Fusion protein of a polypeptide and a heparan sulphate glycosaminoglycan chain which influences binding affinity, binding specificity, and stability; polypeptide of fusion protein can be a cell growth factor, pathogen-related antigen, nuclear protein, cell adhesion molecules, enzyme or enzyme inhibitor |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 02/27/2007 | US7183388 Anti-MUC-1 single chain antibodies for tumor targeting |
| 02/27/2007 | US7183385 Comprises immunoglobulins which bind FMS-related tyrosine kinase 3 (Flt3) receptor for diagnosis and treatment of cancer; immunotherapy |
| 02/27/2007 | US7183382 Mammalian genes; related reagents and methods |
| 02/27/2007 | US7183380 Use in diagnosing and treating neurological conditions and in identification of compounds that alter IMX97018 polypeptide activities |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183108 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 02/27/2007 | US7183105 Eubacterial minicells and their use as vectors for nucleic acid delivery and expression |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183100 Mitigating virulence of mucoid bacteria via exposure to enzyme inhibitors; bactericides and controlling propagation of exopolysaccharide biofilms |
| 02/27/2007 | US7183096 Rapid growing microorganisms for biotechnology applications |
| 02/27/2007 | US7183095 Cell culture system for synthesis of infectious hepatitis C virus |
| 02/27/2007 | US7183083 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 02/27/2007 | US7183082 in vitro and in vivo; involves incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183080 Cannie IL-5 nucleic acid molecules |
| 02/27/2007 | US7183079 Expression vector comprising synthetic promoter and nucleotide sequences coding cecropin proteins for use as tools to enhance disease resistance in catfish; bactericides; parasiticides |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183077 Promoters and gene expression method by using the promoters |
| 02/27/2007 | US7183076 Method for making multispecific antibodies having heteromultimeric and common components |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183070 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders |
| 02/27/2007 | US7183066 Comprises substrate composition for detecting presence of tetanus and botulinum toxoids in neuronal tissues; food poisoning |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7182942 Vaccine immunotherapy for immune suppressed patients |